Clinical Trial Update: Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of lisdexamfetamine on binge eating disorder with functional MRI measurements.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder | Phase 2 | Status: UNKNOWN